Robotic Surgery the New Way Out for Bladder Cancer Patients

Urologic surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center say that they have achieved considerable success in adapting robotic surgery for bladder cancer patients.

Bladder cancer can soon be treated by robotic mechanisms as urologic surgeons at New York-Presbyterian Hospital/Weill Cornell Medical Center say that they have achieved considerable success in adapting robotic surgery for bladder cancer patients.

Describing their work in the British Journal of Urology-International, lead researcher Dr. Douglas Scherr has revealed in the study that the robotic approach provides similar benefits to prostate resection, including dramatically faster recoveries with equal, or better, surgical precision.

The researchers say that, specifically, robotic cystectomy patients have an average hospital stay of five days, compared with eight days for the standard open bladder surgery.

They have revealed that the procedure makes use of Intuitive Surgical's da Vinci Surgical System.

During the surgery, the surgeon makes five to six small incisions in the abdomen, through which surgical instruments and a tiny stereoscopic camera are inserted.

Urinary Incontinence in women - Bladder Diary
The 24-hour bladder diary can provide an accurate record of urinary output, frequency of voiding, frequency and nature of incontinent episodes, as well as type and volume of fluid intake.

Once the bladder is removed, the surgeon creates a new channel for urine to pass from the body.

"While we are only beginning to collect long-term empirical data for the bladder, there are early indications that the surgery is at least as good as open surgery at removing cancer. Our research found that patients treated with robotic surgery had just as good a cancer outcome as those individuals treated at the same center with traditional open surgery," says Dr. Scherr, who has performed more than 100 of the procedures -- believed to be among the highest volume anywhere.

Advertisements

Study Maps Molecular Journey of Bladder Cancer
a whole organ genomic survey that has given them new insights into the molecular basis of bladder cancer.

"Robotics appears to be superior to the standard open technique in selected cases of bladder cancer, and based on results to date, there is every reason to expect the long-term data to show it to have advantages such as reduced recovery time," adds Dr. Scherr, who is clinical director of urologic oncology at New York-Presbyterian Hospital/Weill Cornell Medical Center and the Ronald Stanton Clinical Scholar in Urology and associate professor of urology at Weill Cornell Medical College.

The research team has transformed the care of bladder cancer patients by offering a comprehensive minimally invasive care program, and has been able to perform total urinary reconstruction with neobladders using the robotic approach.